Spine BioPharma
Spine Biopharma has developed a non-surgical solution for those struggling with debilitating back pain.
Launch date
Employees
Market cap
-
Enterprise valuation
$65m (Public information from Oct 2023)
New York City New York (HQ)
Authorizing premium user...